Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Monica Bertagnolli

Surgical Oncology · Harvard Medical School

View

Dr. Philip Schauer

Bariatric Surgery · PBRC

View

Dr. Todd Rosengart

Cardiac Surgery · BCM

View

Dr. Larry Kaiser

Thoracic Surgery · UPenn

View

Dr. Neri Cohen

Thoracic Surgery · XVIVO

View

Dr. Jad M Abdelsattar, M.D, FACS

Breast Surgical Onc · University of Oxford

View

Dr. Lauren Kopicky

Breast Surgical Onc · Cleveland Clinic

View

Dr. Jennifer Plichta

Breast Surgical Onc · Duke University

View

Dr. Sarah Blair

Breast Surgical Onc · UCSD

View

Dr. Karen Goodwin

Breast Surgical Onc · UCSF

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms

    Overview

    Consensus Guideline for the Management of Gastric Cancer with Synchronous Peritoneal Metastases.

    Jun 25, 2025DOI: 10.1245/s10434-025-17361-2Journal ArticleASO

    Written by: Samuel D ButenskyVarun V BansalDavid G SuMuhammad Talha WaheedAndrei NikiforchinJorge L Gomez-MayorgaElizabeth OleckiShannon N RadomskiBeatrice SunKiran K TuragaCraig G GundersonJill LacyBrian D BadgwellHaejin InTimothy KennedyHarry H YoonJonathan B GreerRaghav SundarYanghee WooPeritoneal Surface Malignancies (PSM) Consortium Group

    Find these authors on Roon

    BS
    Dr. Beatrice Sun
    Surgical Oncology · Stanford

    Summary

    BACKGROUND: Gastric cancer with synchronous peritoneal metastases (GCPM) is a debilitating disease with limited treatment options. This manuscript describes an update of the 2018 Chicago Consensus Guidelines addressing the management of GCPM in line with most recent evidence.METHODS: A clinical management pathway was updated through two rounds of a Delphi Consensus to assess agreement levels with pathway blocks. Supporting evidence underwent evaluation via a rapid literature review. Meta-analyses were performed where appropriate.RESULTS: Overall, level of evidence in this disease subset was low to moderate. Of 124 participants in the first round, 109 (88%) responded in the second round. Strong consensus (>90%) was achieved in 6/8 (75%) blocks in round I and II. A multidisciplinary preoperative assessment and diagnostic laparoscopy should be offered to all patients, while patients with a high burden of disease or progression should undergo non-surgical management. Patients with stable/responsive disease and low peritoneal carcinomatosis index should subsequently be offered treatment with regional therapeutic interventions and cytoreductive surgery. In patients who are cytology positive, systemic therapy can be used to convert these patients to cytology negative, with subsequent surgery offered per the patient's goals of care. Meta-analysis of observational and randomized control trials revealed a survival benefit with the addition of intraperitoneal chemotherapy to cytoreductive surgery (HR 0.52).CONCLUSION: The consensus-driven clinical pathway for GCPMs offers vital clinical guidance for practitioners. There is a growing body of high-quality evidence to support management strategies and future clinical trials are eagerly awaited.
    BSDr. Beatrice Sun

    Dr. Beatrice Sun

    Surgery · Surgical Oncology
    Stanford Medicine
    beatrice